SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-001275
Accepted
2023-05-05 00:15:08
Documents
1
Effectiveness Date
2023-05-04
Registration Form
POS AM
Reference AccNo
0001640455-23-000096

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 608
  Complete submission text file 9999999995-23-001275.txt   1701
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-223518 | Film No.: 23891017
SIC: 2836 Biological Products, (No Diagnostic Substances)